Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

The requirements of a specialist breast centre.

Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles CE, Delgado Bolton RC, Trill MD, Erdem S, Fjell M, Geiss R, Goossens M, Kuhl C, Marotti L, Naredi P, Oberst S, Palussière J, Ponti A, Rosselli Del Turco M, Rubio IT, Sapino A, Senkus-Konefka E, Skelin M, Sousa B, Saarto T, Costa A, Poortmans P.

Breast. 2020 Feb 26;51:65-84. doi: 10.1016/j.breast.2020.02.003. [Epub ahead of print]

2.

Basaloid squamous cell carcinoma of the breast.

Marco V, Rubio IT, García F, Clavero O.

Rev Esp Patol. 2020 Apr - Jun;53(2):113-116. doi: 10.1016/j.patol.2019.10.003. Epub 2020 Jan 14.

PMID:
32199592
3.

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial.

Delaloge S, Piccart M, Rutgers E, Litière S, van 't Veer LJ, van den Berkmortel F, Brain E, Dudek-Peric A, Gil-Gil M, Gomez P, Hilbers FS, Khalil Z, Knox S, Kuemmel S, Kunz G, Lesur A, Pierga JY, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Thompson AM, Viale G, Zoppoli G, Vuylsteke P, Tryfonidis K, Poncet C, Bogaerts J, Cardoso F; MINDACT investigators and the TRANSBIG Consortium.

J Clin Oncol. 2020 Feb 21:JCO1901371. doi: 10.1200/JCO.19.01371. [Epub ahead of print]

PMID:
32083990
4.

Theoretical and practical knowledge curriculum for European Breast Surgeons.

Kovacs T, Rubio IT, Markopoulos C, Audisio RA, Knox S, Kühn T, Mansel R, Matrai Z, Meani F, Nava M, Wyld L; BRESO Structure Working Group.

Eur J Surg Oncol. 2020 Apr;46(4 Pt B):717-736. doi: 10.1016/j.ejso.2020.01.027. Epub 2020 Feb 8. Review.

5.

Education and Training in Breast Cancer Surgery in Europe.

Wyld L, Rubio IT, Kovacs T.

Breast Care (Basel). 2019 Dec;14(6):366-372. doi: 10.1159/000502638. Epub 2019 Sep 19. Review.

PMID:
31933582
6.

European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes.

Biganzoli L, Marotti L, Cardoso MJ, Cataliotti L, Curigliano G, Cuzick J, Goldhirsch A, Leidenius M, Mansel R, Markopoulos C, Wyld L, Rubio IT.

Breast Care (Basel). 2019 Dec;14(6):359-365. doi: 10.1159/000503603. Epub 2019 Oct 16. Review.

PMID:
31933581
7.

Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019.

Ditsch N, Rubio IT, Gasparri ML, de Boniface J, Kuehn T.

Curr Opin Obstet Gynecol. 2020 Feb;32(1):91-99. doi: 10.1097/GCO.0000000000000593.

PMID:
31833973
8.

Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment.

Rubio IT, Kontos M, Vrancken-Peeters M, Rouzier R, Skandarajah AR, Galimberti V, Kroman N, Caballero C, Ohno S; BIG Task Force Surgical Trials.

Eur J Surg Oncol. 2020 Apr;46(4 Pt A):501-503. doi: 10.1016/j.ejso.2019.11.503. Epub 2019 Nov 20. No abstract available.

PMID:
31785986
9.

Corrigendum to "About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position" [Breast 46 (August 2019) 95-96].

Cardoso MJ, Biganzoli L, Rubio IT, Leidenius M, Curigliano G, Cutuli B, Marotti L, Kovacs T, Wyld L.

Breast. 2019 Dec;48:103. doi: 10.1016/j.breast.2019.10.010. No abstract available.

10.

Corrigendum to "EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants" [Breast 44 (April 2019) 90-93].

Cardoso MJ, Wyld L, Rubio IT, Leidenius M, Curigliano G, Cutuli B, Marotti L, Biganzoli L.

Breast. 2019 Dec;48:102. doi: 10.1016/j.breast.2019.10.005. No abstract available.

11.

Transforming Breast Cancer Together: European elections manifesto 2019 seizing the opportunities for breast cancer patients.

Cardoso F, Bușoi CS, Cattaneo I, Decise D, Cardone A, Filicevas A, Gentile E, Wierinck L, Knox S, Sebastiani S, Terrasanta C, Ujupan S, Ventura R, Wilson B, Rubio IT.

Breast. 2019 Dec;48:54-57. doi: 10.1016/j.breast.2019.09.003. Epub 2019 Sep 7.

PMID:
31525579
12.

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee.

Ann Oncol. 2019 Oct 1;30(10):1674. doi: 10.1093/annonc/mdz189. No abstract available.

PMID:
31236598
13.

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.

Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.

Ann Oncol. 2019 Aug 1;30(8):1194-1220. doi: 10.1093/annonc/mdz173. No abstract available. Erratum in: Ann Oncol. 2019 Oct 1;30(10):1674. Erratum in: Ann Oncol. 2019 Oct;30(10):1674.

PMID:
31161190
14.

About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position.

Cardoso MJ, Biganzoli L, Rubio IT, M L, G C, B C, L M, Kovacs T, Wyld L.

Breast. 2019 Aug;46:95-96. doi: 10.1016/j.breast.2019.05.005. Epub 2019 May 3. No abstract available. Erratum in: Breast. 2019 Dec;48:103.

PMID:
31125932
15.

European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery.

Evrard S, van de Velde C, Noordhoek I, Caballero C, Ceelen W, Polom K, Kolacinska A, Allum W, D'Ugo D, Malik HZ, Rubio IT, Wyld L, Leidenius M, Rivoire M, Zoras O, Polkowski W, Poston GJ, Audisio RA, Kovacs T, González-Moreno S; on the European Society of Surgical Oncology.

Eur J Surg Oncol. 2019 Sep;45(9):1515-1519. doi: 10.1016/j.ejso.2019.05.004. Epub 2019 May 5. Review.

PMID:
31085024
16.

Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries.

Esgueva A, Rodríguez-Revuelto R, Espinosa-Bravo M, Salazar JP, Rubio IT.

Eur J Surg Oncol. 2019 Apr;45(4):578-583. doi: 10.1016/j.ejso.2019.01.017. Epub 2019 Feb 1.

PMID:
30737056
17.

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.

Colomer R, Saura C, Sánchez-Rovira P, Pascual T, Rubio IT, Burgués O, Marcos L, Rodríguez CA, Martín M, Lluch A.

Oncologist. 2019 May;24(5):603-611. doi: 10.1634/theoncologist.2018-0228. Epub 2019 Feb 1.

18.

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.

Cardoso MJ, Wyld L, Rubio IT, Leidenius M, Curigliano G, Cutuli B, Marotti L, Biganzoli L.

Breast. 2019 Apr;44:90-93. doi: 10.1016/j.breast.2019.01.011. Epub 2019 Jan 26. Erratum in: Breast. 2019 Dec;48:102.

PMID:
30703669
19.

Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey.

Rubio IT, Wyld L, Esgueva A, Kovacs T, Cardoso MJ, Leidenius M, Bianca S, Kolacinska A, Marotti L, Lecoq C, Biganzoli L, Audisio R.

Eur J Surg Oncol. 2019 Apr;45(4):567-572. doi: 10.1016/j.ejso.2019.01.003. Epub 2019 Jan 5.

PMID:
30638809
20.

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation.

Castroviejo-Bermejo M, Cruz C, Llop-Guevara A, Gutiérrez-Enríquez S, Ducy M, Ibrahim YH, Gris-Oliver A, Pellegrino B, Bruna A, Guzmán M, Rodríguez O, Grueso J, Bonache S, Moles-Fernández A, Villacampa G, Viaplana C, Gómez P, Vidal M, Peg V, Serres-Créixams X, Dellaire G, Simard J, Nuciforo P, Rubio IT, Dienstmann R, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Déas O, Jonkers J, Masson JY, Cairo S, Judde JG, O'Connor MJ, Díez O, Balmaña J, Serra V.

EMBO Mol Med. 2018 Dec;10(12). pii: e9172. doi: 10.15252/emmm.201809172.

21.

Percutaneous ultrasound-guided vacuum-assisted excision of benign breast lesions: A learning curve to assess outcomes.

Salazar JP, Miranda I, de Torres J, Rus MN, Espinosa-Bravo M, Esgueva A, Salvador R, Rubio IT.

Br J Radiol. 2019 Feb;92(1094):20180626. doi: 10.1259/bjr.20180626. Epub 2018 Nov 29.

22.

ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.

Rubio IT.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):638-639. doi: 10.1245/s10434-018-6849-z. Epub 2018 Oct 3. No abstract available.

PMID:
30284130
23.

Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.

Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blättler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M.

Breast Cancer Res Treat. 2018 Dec;172(3):523-537. doi: 10.1007/s10549-018-4937-1. Epub 2018 Sep 4. Review.

24.

Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?

Rubio IT, Wyld L, Cardoso F, Curigliano G, Kovacs T, Poortmans P, Cortes J.

Breast. 2018 Oct;41:133-135. doi: 10.1016/j.breast.2018.07.008. Epub 2018 Jul 23.

PMID:
30056250
25.

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.

Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson C.

Cancer. 2018 Jul 15;124(14):2923-2930. doi: 10.1002/cncr.31518. Epub 2018 May 3.

26.

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN, Kristel P, de Bustos L, Guzman M, Rodríguez O, Grueso J, Montalban G, Caratú G, Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O, O'Connor MJ, Balmaña J, Serra V.

Ann Oncol. 2018 May 1;29(5):1203-1210. doi: 10.1093/annonc/mdy099.

27.

Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Volders JH, Negenborn VL, Spronk PE, Krekel NMA, Schoonmade LJ, Meijer S, Rubio IT, van den Tol MP.

Breast Cancer Res Treat. 2018 Feb;168(1):13-15. doi: 10.1007/s10549-017-4632-7.

28.

A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.

Bastiaannet E, Charman J, Johannesen TB, Schrodi S, Siesling S, van Eycken L, Walsh PM, Audisio RA, Boelens PG, Rubio IT, Jones N, Lewis J, van de Velde CJH.

Clin Breast Cancer. 2018 Aug;18(4):e613-e619. doi: 10.1016/j.clbc.2017.11.019. Epub 2017 Nov 29.

29.

Variations in the opinion of breast surgeons and radiation oncologist regarding indications for radiation therapy after NSM: The need for prospective studies.

Rubio IT.

Eur J Surg Oncol. 2018 Jan;44(1):3-4. doi: 10.1016/j.ejso.2017.11.020. Epub 2017 Dec 2. No abstract available.

PMID:
29224984
30.

Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes.

Volders JH, Negenborn VL, Spronk PE, Krekel NMA, Schoonmade LJ, Meijer S, Rubio IT, van den Tol MP.

Breast Cancer Res Treat. 2018 Feb;168(1):1-12. doi: 10.1007/s10549-017-4598-5. Epub 2017 Dec 6. Erratum in: Breast Cancer Res Treat. 2018 Jan 11;:.

31.

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.

Siso C, de Torres J, Esgueva-Colmenarejo A, Espinosa-Bravo M, Rus N, Cordoba O, Rodriguez R, Peg V, Rubio IT.

Ann Surg Oncol. 2018 Mar;25(3):784-791. doi: 10.1245/s10434-017-6270-z. Epub 2017 Dec 1.

PMID:
29197044
32.

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.

Cardoso F, Bartlett JMS, Slaets L, van Deurzen CHM, van Leeuwen-Stok E, Porter P, Linderholm B, Hedenfalk I, Schröder C, Martens J, Bayani J, van Asperen C, Murray M, Hudis C, Middleton L, Vermeij J, Punie K, Fraser J, Nowaczyk M, Rubio IT, Aebi S, Kelly C, Ruddy KJ, Winer E, Nilsson C, Dal Lago L, Korde L, Benstead K, Bogler O, Goulioti T, Peric A, Litière S, Aalders KC, Poncet C, Tryfonidis K, Giordano SH.

Ann Oncol. 2018 Feb 1;29(2):405-417. doi: 10.1093/annonc/mdx651.

33.

Erratum to: Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.

Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M.

Breast Cancer Res Treat. 2017 Nov;166(2):337. doi: 10.1007/s10549-017-4457-4. No abstract available.

34.

Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients.

Ahmed M, Jozsa F, Baker R, Rubio IT, Benson J, Douek M.

Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Review. Erratum in: Breast Cancer Res Treat. 2017 Nov;166(2):337.

35.

Global Forum of Cancer Surgeons: Declaration of Intent.

Are C, Coit DG, McMasters KM, Giuliano AE, Anderson BO, Balch CM, Pathak KA, Audisio RA, Rubio IT, Gonzalez-Moreno S, Mori M, Eguchi H, Savant D, Prasad BKCM, Cheema MA, Chaudhry ZA, Yang HK, Park DJ, Coimbra FJF, Quadros C, Said HM, Bargallo-Rocha JE.

Ann Surg Oncol. 2017 Sep;24(9):2429-2431. doi: 10.1245/s10434-017-5951-y. Epub 2017 Jul 5. No abstract available.

PMID:
28676922
36.

Breast implant associated anaplastic large cell lymphoma: Impact and implications.

Wyld L, Rubio IT.

Eur J Surg Oncol. 2017 Aug;43(8):1383-1384. doi: 10.1016/j.ejso.2017.06.001. Epub 2017 Jun 12. No abstract available.

PMID:
28634013
37.

Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.

Peg V, Sansano I, Vieites B, Bernet L, Cano R, Córdoba A, Sancho M, Martín MD, Vilardell F, Cazorla A, Espinosa-Bravo M, Pérez-García JM, Cortés J, Rubio IT, Ramón Y Cajal S.

Breast. 2017 Jun;33:8-13. doi: 10.1016/j.breast.2017.02.011. Epub 2017 Feb 28.

PMID:
28254641
38.

Intraoperative assessment of sentinel lymph node by one-step nucleic acid amplification in breast cancer patients after neoadjuvant treatment reduces the need for a second surgery for axillary lymph node dissection.

Espinosa-Bravo M, Navarro-Cecilia J, Ramos Boyero M, Diaz-Botero S, Dueñas Rodríguez B, Luque López C, Ramos Grande T, Ruano Perez R, Peg V, Rubio IT.

Breast. 2017 Feb;31:40-45. doi: 10.1016/j.breast.2016.10.002. Epub 2016 Nov 2.

PMID:
27810698
39.

Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer.

Ahmed M, Baker R, Rubio IT.

Br J Surg. 2016 Nov;103(12):1579-1588. doi: 10.1002/bjs.10289. Epub 2016 Sep 6. Review.

PMID:
27598038
40.

Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts.

Morancho B, Zacarías-Fluck M, Esgueva A, Bernadó-Morales C, Di Cosimo S, Prat A, Cortés J, Arribas J, Rubio IT.

Oncotarget. 2016 Oct 18;7(42):67956-67965. doi: 10.18632/oncotarget.11815.

41.

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators.

N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253.

42.

The cancer stem-cell signaling network and resistance to therapy.

Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME.

Cancer Treat Rev. 2016 Sep;49:25-36. doi: 10.1016/j.ctrv.2016.07.001. Epub 2016 Jul 9. Review.

PMID:
27434881
43.

Different Prognostic Implications of Residual Disease After Neoadjuvant Treatment: Impact of Ki 67 and Site of Response.

Diaz-Botero S, Espinosa-Bravo M, Gonçalves VR, Esgueva-Colmenarejo A, Peg V, Perez J, Cortes J, Rubio IT.

Ann Surg Oncol. 2016 Nov;23(12):3831-3837. Epub 2016 Jun 29.

PMID:
27357178
44.

Intraoperative ultrasound guided breast surgery: paving the way for personalized surgery.

Espinosa-Bravo M, Rubio IT.

Gland Surg. 2016 Jun;5(3):366-8. doi: 10.21037/gs.2016.03.06. No abstract available.

45.

Clinical utility of Axillary Reverse Mapping (ARM) in an era of changing perceptions concerning axillary surgery.

Luiten EJ, Beek MA, Rubio IT.

Eur J Surg Oncol. 2016 May;42(5):585-7. doi: 10.1016/j.ejso.2016.01.022. Epub 2016 Feb 10. No abstract available.

PMID:
26898840
46.

Margins in breast conserving surgery: A practice-changing process.

Rubio IT, Ahmed M, Kovacs T, Marco V.

Eur J Surg Oncol. 2016 May;42(5):631-40. doi: 10.1016/j.ejso.2016.01.019. Epub 2016 Feb 3. Review.

PMID:
26880017
47.

Sentinel lymph node biopsy after neoadjuvant treatment in breast cancer: Work in progress.

Rubio IT.

Eur J Surg Oncol. 2016 Mar;42(3):326-32. doi: 10.1016/j.ejso.2015.11.018. Epub 2015 Dec 17. Review.

PMID:
26774943
48.

Sentinel lymph node metastasis after neoadjuvant treatment in breast cancer: Any size matters?

Rubio IT.

World J Clin Oncol. 2015 Dec 10;6(6):202-6. doi: 10.5306/wjco.v6.i6.202.

49.

Systematic review of axillary reverse mapping in breast cancer.

Ahmed M, Rubio IT, Kovacs T, Klimberg VS, Douek M.

Br J Surg. 2016 Feb;103(3):170-8. doi: 10.1002/bjs.10041. Epub 2015 Dec 10. Review.

PMID:
26661686
50.

Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment.

Rubio IT, Esgueva-Colmenarejo A, Espinosa-Bravo M, Salazar JP, Miranda I, Peg V.

Ann Surg Oncol. 2016 Jan;23(1):38-43. doi: 10.1245/s10434-015-4935-z. Epub 2015 Oct 29.

PMID:
26514120

Supplemental Content

Loading ...
Support Center